patience rewarded, page-24

Well Bud good luck to you and I must admit after following this stock for 4 odd years the selling has been very solid since the last quarter result.Someone wants out or its a great job of capping.

Apart from the share price things seem to be going very well.

Compare PXS with CST and you will see CST is very cheap in comparision.PXS are hoping for European approval in 18 months and FDA in 3 years.The only thing in PXSs favour is PR which we have never had.

Regards,